Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review

Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels

(2015) Shailja Shah et al.   AIDS

Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patients

(2014) Paula Freitas et al.   BMC INFECTIOUS DISEASES

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement

(2014) Nigel Field et al.   LANCET INFECTIOUS DISEASES

Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda

(2014) Isaac Ssinabulya et al.   PLoS One

Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV

(2014) Joaquín Portilla et al.   Journal of the International AIDS Society

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection

(2013) Chris T. Longenecker et al.   AIDS

Perturbations of Circulating Levels of RANKL-Osteoprotegerin Axis in Relation to Lipids and Progression of Atherosclerosis in HIV-Infected and -Uninfected Adults: ACTG NWCS 332/A5078 Study

(2013) Theodoros Kelesidis et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study

(2013) Corrilynn O Hileman et al.   ANTIVIRAL THERAPY

Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy

(2013) Jason D. Barbour et al.   ATHEROSCLEROSIS

Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study

(2013) Andreas Knudsen et al.   BMC INFECTIOUS DISEASES

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study

(2013) Andrea De Luca et al.   BMC INFECTIOUS DISEASES

Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients

(2013) A. Mangili et al.   CLINICAL INFECTIOUS DISEASES

Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals

(2013) CT Longenecker et al.   HIV MEDICINE

Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals

(2013) Clare L V Westhorpe et al.   IMMUNOLOGY AND CELL BIOLOGY

C-Reactive Protein Predicts 96-Week Carotid Intima Media Thickness Progression in HIV-Infected Adults Naive to Antiretroviral Therapy

(2013) Corrilynn O. Hileman et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses

(2013) Peter Willeit et al.   PLoS One

Increased Carotid Intima-Media Thickness Associated with Antibody Responses to Varicella-Zoster Virus and Cytomegalovirus in HIV-Infected Patients

(2013) Mar Masiá et al.   PLoS One

Immune Activation and Collateral Damage in AIDS Pathogenesis

(2013) Frank Miedema et al.   Frontiers in Immunology

Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection

(2012) James H. Stein et al.   AIDS

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

(2012) Alison J. Rodger et al.   AIDS

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

(2012) Stefania Piconi et al.   AIDS

Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment

(2012) Robert C. Kaplan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV Infection and Coronary Heart Disease: An Intersection of Epidemics

(2012) Virginia A. Triant   JOURNAL OF INFECTIOUS DISEASES

Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults

(2012) Priscilla Y. Hsue et al.   JOURNAL OF INFECTIOUS DISEASES

Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection

(2012) Theodoros Kelesidis et al.   JOURNAL OF INFECTIOUS DISEASES

Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study

(2012) Jeffrey K. Lee et al.   PLoS One

T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis

(2012) Esther Merlini et al.   PLoS One

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

(2012) Daniel A. Duprez et al.   PLoS One

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

(2011) Jason V. Baker et al.   AIDS

Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy

(2011) Su Jin Jeong et al.   ATHEROSCLEROSIS

Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort

(2011) J. V. Baker et al.   CLINICAL INFECTIOUS DISEASES

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

(2011) Netanya G. Sandler et al.   JOURNAL OF INFECTIOUS DISEASES

Atherosclerosis: current pathogenesis and therapeutic options

(2011) Christian Weber et al.   NATURE MEDICINE

Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

(2010) Emily S Ford et al.   AIDS

Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

(2010) Marisa Tungsiripat et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

(2009) Priscilla Y Hsue et al.   AIDS

The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries

(2009) Koon Teo et al.   AMERICAN HEART JOURNAL

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy

(2009) Allison C. Ross et al.   CLINICAL INFECTIOUS DISEASES

Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation

(2009) S Parra et al.   HIV MEDICINE

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)

(2009) Charlotte Lewden et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction

(2009) Virginia A Triant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Carotid intima‐media thickness and markers of inflammation, endothelial damage and hemostasis

(2008) Damiano Baldassarre et al.   ANNALS OF MEDICINE

Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors

(2008) Raaj R. Sankatsing et al.   ATHEROSCLEROSIS

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients

(2008) S. Badiou et al.   JOURNAL OF INFECTION